In August 2025, a federal district court in Texas delivered a landmark ruling with significant implications for the Medicare Advantage (MA) and Part D markets. The court vacated the Centers for Medicare & Medicaid Services’ (CMS) attempt to impose new limits on broker and third-party marketing organization (TPMO) compensation. The decision halts CMS’s effort to...
